| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/14/2001 | EP1075267A2 Treatment of celiac disease |
| 02/14/2001 | EP1075266A1 Hematopoietic stimulation |
| 02/14/2001 | EP1075265A1 Use of tetracyclines for treating meibomian gland disease |
| 02/14/2001 | EP1075264A1 New drug combinations of a n.a.r.i., preferably reboxetine, and pindolol |
| 02/14/2001 | EP1075263A1 Aqueous process for manufacturing paroxetine solid dispersions |
| 02/14/2001 | EP1075262A1 Desmethylpantoprazole compositions and methods |
| 02/14/2001 | EP1075261A1 Mycobacterial inhibitors |
| 02/14/2001 | EP1075260A2 Novel fatty acid analogues for the treatment of primary and secondary restenosis |
| 02/14/2001 | EP1075259A1 Novel fatty analogues for the treatment of diabetes |
| 02/14/2001 | EP1075258A1 Novel fatty analogues for the treatment of obesity, hypertension and fatty liver |
| 02/14/2001 | EP1075257A1 Use of triclosan for the treatment of helicobacter pylori infections |
| 02/14/2001 | EP1075256A1 Arylhydrocarbon receptor ligand antagonists |
| 02/14/2001 | EP1075255A1 Inhibition of binding of hox and homeodomain-containing proteins and uses thereof |
| 02/14/2001 | EP1075254A2 The use of polyamines in the treatment of dermatological symptoms |
| 02/14/2001 | EP1075191A1 Phytosterol compositions |
| 02/14/2001 | EP1075186A1 Method of hsv prophylaxis |
| 02/14/2001 | EP0994743A4 Treatment of inflammatory disorders of the bowel and urinary bladder |
| 02/14/2001 | EP0968226A4 G-rich oligo aptamers and methods of modulating an immune response |
| 02/14/2001 | EP0844874A4 METHODS AND COMPOSITIONS USEFUL FOR INHIBITION OF ALPHA v BETA 5 MEDIATED ANGIOGENESIS |
| 02/14/2001 | EP0842170B1 Diphenylmethylene piperidine derivatives |
| 02/14/2001 | EP0833820B1 Benzisoxazole and indazole derivatives as antipsychotic agents |
| 02/14/2001 | EP0828714B1 Method for making quinolone carboxylic acids or naphthyridine carboxylic acids in free base form |
| 02/14/2001 | EP0815120B1 17-difluoromethylene-oestratrienes |
| 02/14/2001 | EP0773964B1 Gas phase production of polydienes |
| 02/14/2001 | EP0714897B1 Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
| 02/14/2001 | EP0643071B1 Compound for inhibiting bone resorption and accelerating osteogenesis |
| 02/14/2001 | EP0607198B1 Preparation of improved alkylpolyglycoside surfactant mixtures |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/14/2001 | CN1284081A Novel macrolides compounds |
| 02/14/2001 | CN1284079A Novel compounds |
| 02/14/2001 | CN1284078A Heterocycilc compounds for inhibition of gastric acid secretion, processes for their prepn. and pharmaceutical compsns thereof |
| 02/14/2001 | CN1284077A Purine derivatives having phosphodiesterase IV inhibition activity |
| 02/14/2001 | CN1284076A 2-aryl-8-oxodihydropurine derivatives, process for producting same, medicinal conty. same, and intermediates thereof |
| 02/14/2001 | CN1284074A Novel compounds |
| 02/14/2001 | CN1284073A 5-(2-imidazolinylamino)-benzimidazole derivatives, their prepn. and their use as alpha-adrenoceptor agonists with inproved metabolic stability |
| 02/14/2001 | CN1284072A Prodrugs of aspartyl protease inhibitors |
| 02/14/2001 | CN1284071A Sulphona mide derivatives as prodrugs of aspartyl protease inhibitors |
| 02/14/2001 | CN1284066A Substituted inidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 02/14/2001 | CN1284064A 2,3-substituted indole compounds as cox-2 inhibitors |
| 02/14/2001 | CN1284060A Novel metalloproteinase inhibitors |
| 02/14/2001 | CN1284059A Biphenylamidine derivatives |
| 02/14/2001 | CN1284058A Neuroprotective agents |
| 02/14/2001 | CN1284057A Adamantane derivatives |
| 02/14/2001 | CN1284056A Anticonvulsant and sentral nervous system-active bis (fluorophenyl) alkylamides |
| 02/14/2001 | CN1283996A Method/thiol biochdes |
| 02/14/2001 | CN1283995A Antiviral compounds |
| 02/14/2001 | CN1283994A Methods for treatment of neuro-and nephro-disorders and therapeutic toxicities using aminothiol compounds |
| 02/14/2001 | CN1283993A Method for producing solid dosing forms |
| 02/14/2001 | CN1283992A Sustained release drug delivery device |
| 02/14/2001 | CN1283991A Soft-pellet drug and process for prepn, thereof |
| 02/14/2001 | CN1283990A Long cating injectable formulations contg. hydrogenated castor oil |
| 02/14/2001 | CN1283983A Improved personal formulations |
| 02/14/2001 | CN1283633A Carboxynethylated derivative of ganoderic alpha-(1-3)-D-glucosan and its usage and preparing process |
| 02/14/2001 | CN1283632A Ganoderic alpha-(1-3)-D-glucosan sulfate derivative and its usage and preparing process |
| 02/14/2001 | CN1283624A Process for preparing 'Xidinafei' medicine |
| 02/14/2001 | CN1283623A 1,2,4,5-tetrahydro-benzo[d] azepine compound |
| 02/14/2001 | CN1283622A 6-hydroxy-3(4-[2-(piperidine-1-group)oxyethyl group]phenoxy)-2-(4-methoxy phenyl) benzo[b] thiophene hydrochloride salt |
| 02/14/2001 | CN1283488A Medicinal composition for treating alopesia |
| 02/14/2001 | CN1283483A Anticancer capsule 'Wushensu' and its extracting and preparing process |
| 02/14/2001 | CN1283482A Medicinal composition for treating cardiovascular disease and its preparing process |
| 02/14/2001 | CN1283480A Medicine for treating piles |
| 02/14/2001 | CN1283478A 'Yidaosheng' capsules |
| 02/14/2001 | CN1283473A Medicine for treating cardiovascular and cerebrovascular apoplexy and applexy aurae and its preparing process |
| 02/14/2001 | CN1283469A Compound tablet 'Changning' and its preparing process |
| 02/14/2001 | CN1283468A Compound tablet 'Changning' and its preparing process |
| 02/14/2001 | CN1283466A Powdered medicine 'Kouqiangyanhousan' and its preparing process |
| 02/14/2001 | CN1283464A High-molecular medicine resisting tumor metastasis and its preparing process |
| 02/14/2001 | CN1283463A Process for preparing solid-state-microspherical vascular suppository of sodium alginate |
| 02/14/2001 | CN1283462A Application of astragalin A in preparing medicinal composition |
| 02/14/2001 | CN1283461A Antiparasitic pre-mixture containing evericin, ivermection or acetylamino evericin for fish, shrimp and crab |
| 02/14/2001 | CN1283460A Application of respiratory chain buiquinone depressant in preventing thrombolytic reperfusion damage |
| 02/14/2001 | CN1283459A Medicine for curing bronchial asthma and asthmatic chronic bronchitis and its preparing process |
| 02/14/2001 | CN1283458A Compound dihydroartemisinin as new antimalarial |
| 02/14/2001 | CN1283457A Medicine for treating hircus |
| 02/14/2001 | CN1283456A Compound for treating cancers of mammal |
| 02/14/2001 | CN1283455A Application of black fading hormone and black fading ligand in medicinal compsns for prevention and treatment of gastrointestional tract disease |
| 02/14/2001 | CN1283454A Method for preparing pellet contg fat-soluble substances |
| 02/14/2001 | CN1283451A Local compsn, contg, tocopherol |
| 02/14/2001 | CN1283447A Locally-used weight reducing face-care compsns. |
| 02/14/2001 | CN1283418A Compound chitosane for additive for discharging lead |
| 02/14/2001 | CN1283413A Skin-care agent, health and face-care foodstuff |
| 02/14/2001 | CN1061983C 4-trifluoromethyl-3-ketosteroid compound and synthesizing method thereof |
| 02/14/2001 | CN1061977C Aryl substituted heterocycles |
| 02/14/2001 | CN1061859C Medicine for treating hircismus |
| 02/14/2001 | CN1061855C Compound drug for treating rheumatism |
| 02/14/2001 | CN1061844C External-use antithyroid cream |
| 02/13/2001 | USRE37053 Particles incorporating surfactants for pulmonary drug delivery |
| 02/13/2001 | US6187944 A phenyl acrylonitrile compounds useful as active ingredients of an insecticide, a miticide, a nematicide, a soil pesticide, a fungicide and a marine antifouling agent |
| 02/13/2001 | US6187933 Bind to retinoid receptors; treating skin disorders |
| 02/13/2001 | US6187932 Subjecting n-(d-alpha-methyl-beta-acylthiopropionyl)-l-proline to hydrolysis reaction in aqueous medium in presence of strong acid at specified temperature to remove acyl group, isolating captopril |
| 02/13/2001 | US6187930 Reacting selected amine with optically active acid selected from (+)-ditoluyl-l-tartaric acid and/or (-)-ditoluyl-l-tartaric acid in solvent to form diasteroisomeric salt, separating, isolating enantiomer |
| 02/13/2001 | US6187905 Peptide compound which inhibits viral proteinases; viricides for hepatitis c, hepatitis g, and human gb viruses |
| 02/13/2001 | US6187822 To inhibit adenosine diphosphate-ribosylation of vascular endothelial growth factor, wherein the enzyme inhibitor is selected from vitamin k1, vitamin k3, novobiocin, and silybin; healing wounds such as diaper dermatitis |
| 02/13/2001 | US6187820 Administering compounds such as n,n-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl)-3-methylbutylamine hydrochloride for prophylaxis or treatment of hyperlipidemia, hypercholesterolemia or hypertriglyceridemia |
| 02/13/2001 | US6187819 Protein kinase C activators and their use in decreasing expression of cell antigens |
| 02/13/2001 | US6187818 Prostaglandins formulation and process |
| 02/13/2001 | US6187817 Preventing or reducing ototoxicity in a human, cat or dog by administering d-methionine free of the l-isomer |
| 02/13/2001 | US6187815 Topically applying procaine and niacin in given dosage amount in a topical hydrophilic vehicle |
| 02/13/2001 | US6187814 By topically an farnesoid x-activated receptor (fxr) activator selected from farnesal, alkyl farnesyl ether, alkyl farnesoate, and 7-methyl-9-(3,3-dimethyloxiranyl)-3-methyl-2,6-nonadienoic acid, alkyl ester |